Premier Alternatives

GeneCapture

Huntsville, AL · Founded 2009 · Privately Held (backing)

Developer of a medical diagnostic device designed to detect and identify pathogens and to bring infection detection to the point of care. GeneCapture is based in Huntsville, AL and was founded in 2009. Its last reported valuation was $23.5 million in Sep 2021. It has raised $7.4 million across 2 recorded rounds; the latest was a $500,000 seed round in Nov 2024.

Last reported valuation
$23.5M
Oct 2026
Priced at
—
Total raised
$7.4M
Last round
Seed Round
Nov 2024

GeneCapture key facts

as of Oct 2026
  • Developer of a medical diagnostic device designed to detect and identify pathogens and to bring infection detection to the point of care.
  • GeneCapture is valued at approximately $23.5M as of Oct 2026 (last reported valuation).
  • It has raised $7.4M across 2 recorded rounds; the latest was Seed Round ($500K) in Nov 2024.
  • Notable investors include United States Department of War, First Avenue Ventures, Air Force Research Laboratory, Alabama Launchpad, Coplanar Capital — 11 tracked in total.
  • GeneCapture has filed 10 Form Ds with the SEC since 2012, most recently Dec 2024 ($500K sold to 1 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$23.5M

GeneCapture's last reported valuation, Sep 2021. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of GeneCapture with a free account
  • ·The complete investor list: 11 names
  • ·Watch GeneCapture: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

GeneCapture funding rounds

2 rounds
Nov 2024Seed Round$500KSEC filing▮
Sep 2021Seed Round$1.2MSEC filing▮
Full funding history →

GeneCapture valuation

GeneCapture's last reported valuation was $23.5 million in Sep 2021. No priced round, secondary trade or fund mark has surfaced since.

How much has GeneCapture raised?

GeneCapture has raised $7.4 million in total; 2 of its rounds are on record. The largest on record was a $500,000 seed round in Nov 2024.

GeneCapture has filed 10 Form Ds with the SEC since 2012, most recently in Dec 2024 ($500,000 sold to 1 investor).

GeneCapture investors

11 investors are on record for GeneCapture, including United States Department of War, First Avenue Ventures, Air Force Research Laboratory and Alabama Launchpad. The seed round in Nov 2024 drew 1 investor.

About GeneCapture

Developer of a medical diagnostic device designed to detect and identify pathogens and to bring infection detection to the point of care. The company's device screens germs in blood, urine and wounds against a wide array of genetic signatures and reports the results within an hour, enabling medical professionals to detect bacterial and viral infections in a portable instrument for use in clinics, field applications, airports and at borders.

Sector
Healthcare
HQ
Huntsville, AL, United States
Founded
2009
Employees
23
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.